Asare A, Previs RA, Spinosa D, Fellman B, et al. Bevacizumab beyond progression: Impact of subsequent bevacizumab re-treatment in patients with ovarian, fallopian tube, and peritoneal cancer after progression. Gynecol Oncol 2025;194:112-118.
PMID: 39987772